Русский
Optimization of prevention of infectious complications during prostate biopsy
DOI: https://dx.doi.org/10.18565/urology.2023.6.128-132
Kolontarev K.B., Stroganov R.V., Pushkar D.Yu.
1) Moscow Urological Center of S.P. Botkin City Clinical Hospital, Moscow, Russia; 2) Department of Urology of Scientific and Educational Institute of the Clinical Medicine named after N.A. Semashko FGBOU VO «Russian University of Medicine», Moscow, Russia
Prostate cancer (PCa) is one of the most common malignant neoplasms in middle-aged and elderly men. Transrectal ultrasound guided prostate biopsy is the standard method for diagnosing prostate cancer but is associated with a high incidence of infectious compli-cations.
A review of the literature on optimizing the prevention of infectious complications when performing transrectal prostate biopsy is presented. The main risk factors and the common measures to prevent the development of complications are discussed, including a study of using fosfomycin trometamol as the preferred drug for antibacterial prophylaxis. Fosfomycin meets the requirements for empirical prophylaxis, but further clinical studies are needed.
A review of the literature on optimizing the prevention of infectious complications when performing transrectal prostate biopsy is presented. The main risk factors and the common measures to prevent the development of complications are discussed, including a study of using fosfomycin trometamol as the preferred drug for antibacterial prophylaxis. Fosfomycin meets the requirements for empirical prophylaxis, but further clinical studies are needed.
About the Autors
Corresponding author: K.B. Kolontarev – Ph.D., MD, Deputy Chief of the Moscow Urological Center of S.P. Botkin City Clinical Hospital, professor at the Department of Urology of Scientific and Educational Institute of the Clinical Medicine named after N.A. Semashko FGBOU VO «Russian University of Medicine», Moscow, Russia; e-mail: kb80@yandex.ru
Similar Articles
